ArticleMolecular cancer therapeutics2021

Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models.

Takuya Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.